Description: Science 37's mission is to enable universal access to clinical research—making it easier for patients and providers to participate from nearly anywhere and helping to accelerate the development of treatments that impact patient lives. As a pioneer of decentralized clinical trials, the Science 37 Clinical Trial Operating System (OS) supports today’s more agile clinical research designs with its full stack, end-to-end technology platform and specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators and connected devices. Configurable to enable any study type, the Science 37 OS can enable up to 15x faster enrollment, 28% better retention and 3x more diverse patient population with industry-leading workflow orchestration, evidence generation and data harmonization.
Home Page: www.science37.com
SNCE Technical Analysis
800 Park Offices Drive
Research Triangle Park,
NC
27709
United States
Phone:
984 377 3737
Officers
| Name | Title |
|---|---|
| Mr. David Coman | CEO & Director |
| Ms. Christine A. Pellizzari J.D. | Chief Legal & HR Officer and Sec. |
| Mr. Mike Zaranek | Chief Financial Officer |
| Troy Bryenton | Chief Technology Officer |
| Ms. Margie Gimbel Kooman | VP of Marketing & Communications |
| Mr. Drew Bustos | Chief Strategy & Marketing Officer |
| Mr. Jonathan Cotliar M.D. | Chief Medical Officer |
| Ms. Darcy Forman | Chief Delivery Officer |
| Ms. Elisa Cascade | Chief Product Officer |
| Mr. Michael Shipton | Chief Commercial Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.3653 |
| Price-to-Sales TTM: | 0.7664 |
| IPO Date: | 2020-11-20 |
| Fiscal Year End: | December |
| Full Time Employees: | 601 |